1643 — Modern Chinese Medicine Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$496.80m
- HK$246.38m
- CNY214.07m
- 74
- 51
- 64
- 72
Annual cashflow statement for Modern Chinese Medicine Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 90.5 | 114 | 124 | 68.3 | 14.8 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 1.95 | -0.788 | 5.44 | 0.385 | 9.42 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -51.5 | -58.6 | -9.67 | -66.7 | 25.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 42.8 | 57.6 | 126 | 8.48 | 59 |
| Capital Expenditures | -0.544 | -70.5 | -11.7 | -5.1 | -114 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.136 | 0.421 | 0.675 | 0.906 | -1.18 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.408 | -70 | -11 | -4.19 | -115 |
| Financing Cash Flow Items | -4.72 | -26.7 | -0.014 | -0.005 | -0.001 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -5.05 | 116 | -8.73 | -0.326 | -0.144 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 37.3 | 103 | 106 | 4.01 | -56.6 |